Shown: posts 1 to 2 of 2. This is the beginning of the thread.
Posted by PeterMartin on May 6, 2022, at 22:12:32
New paper published in JAMA today. Full data in the supplemental tables if interested: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791969
--May 6, 2022
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York Statewide Psychiatric Hospital SystemAbstract
Importance
Individuals with serious mental illness are at increased risk of severe COVID-19 infection. Several psychotropic medications have been identified as potential therapeutic agents to prevent or treat COVID-19 but have not been systematically examined in this population.Objective
To evaluate the associations between the use of psychotropic medications and the risk of COVID-19 infection among adults with serious mental illness receiving long-term inpatient psychiatric treatment.Design, Setting, and Participants
This retrospective cohort study assessed adults with serious mental illness hospitalized in a statewide psychiatric hospital system in New York between March 8 and July 1, 2020. The final date of follow-up was December 1, 2020. The study included 1958 consecutive adult inpatients with serious mental illness (affective or nonaffective psychoses) who received testing for SARS-CoV-2 by reverse transcriptasepolymerase chain reaction or antinucleocapsid antibodies and were continuously hospitalized from March 8 until medical discharge or July 1, 2020.Exposures
Psychotropic medications prescribed prior to COVID-19 testing.Main Outcomes and Measures
COVID-19 infection was the primary outcome, defined by a positive SARS-CoV-2 reverse transcriptasepolymerase chain reaction or antibody test result. The secondary outcome was COVID-19related death among patients with laboratory-confirmed infection.Results
Of the 2087 adult inpatients with serious mental illness continuously hospitalized during the study period, 1958 (93.8%) underwent testing and were included in the study; 1442 (73.6%) were men, and the mean (SD) age was 51.4 (14.3) years. A total of 969 patients (49.5%) had laboratory-confirmed COVID-19 infection that occurred while they were hospitalized; of those, 38 (3.9%) died. The use of second-generation antipsychotic medications, as a class, was associated with decreased odds of infection (odds ratio [OR], 0.62; 95% CI, 0.45-0.86), whereas the use of mood stabilizers was associated with increased odds of infection (OR, 1.23; 95% CI, 1.03-1.47). In a multivariable model of individual medications, the use of paliperidone was associated with decreased odds of infection (OR, 0.59; 95% CI, 0.41-0.84), and the use of valproic acid was associated with increased odds of infection (OR, 1.39; 95% CI, 1.10-1.76). Clozapine use was associated with reduced odds of mortality in unadjusted analyses (unadjusted OR, 0.25; 95% CI, 0.10-0.62; fully adjusted OR, 0.43; 95% CI, 0.17-1.12).Conclusions and Relevance
In this cohort study of adults hospitalized with serious mental illness, the use of second-generation antipsychotic medications was associated with decreased risk of COVID-19 infection, whereas the use of valproic acid was associated with increased risk. Further research is needed to assess the mechanisms that underlie these findings.
Posted by SLS on May 7, 2022, at 9:13:27
In reply to Assoc Between Psych Medication + COVID risk:, posted by PeterMartin on May 6, 2022, at 22:12:32
I didn't read the paper. I don't have the time.
Studying COVID and the entirety of the pharmocopia is very helpful. Using the criterion of "psychotropic" as the drugs tested is short-sighted and could sabotage some people's remissions if the specific drugs tested aren't identified along with the statistical risk of producing COVID for each drug separately. I doubt every drug pigeon-holed as bein a "psychotropic" drug was tested to make such a sweeping statement. Lithium, Nardil, Levoxyl, Saphris, Thorazine, clomipramine, psilycibin, etc. Well, I'm sure that illustrates the point. Since I didn't read the article, were the results presented in this fashion?
- Scott
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.